Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Pharmacology in Drug Development is Scopus-indexed (Q2, CiteScore 3.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Blackwell.
Checked against the index lists dated .
ISSN 2160-763XVerify ISSN ↗2160-7648Verify ISSN ↗
Publisher: Wiley-Blackwell
Cost to publish: About US$3,800 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 90 / 191 | 53rd | Q2 |
| Pharmacology (medical) | 154 / 278 | 44th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 3.4.
Clinical Pharmacology in Drug Development is Q2 in Pharmaceutical Science (rank 90 of 191) and Q3 in Pharmacology (medical) (rank 154 of 278), by CiteScore 2025.
Clinical Pharmacology in Drug Development is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.4, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.553, quartile Q2, with an H-index of 42.
The publisher lists an article processing charge of about US$3,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical Pharmacology in Drug Development is published by Wiley-Blackwell. Its print ISSN is 2160-763X and its online ISSN is 2160-7648.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical Pharmacology in Drug Development has an h-index of 46 and a 2-year mean of 1.45 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q2. On 2-year citations it ranks #95 of 177 Scopus journals in Pharmaceutical Science.
Clinical Pharmacology in Drug Development published 153 papers in 2025; its busiest recent year was 2022 with 174. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from China (32.8%), United States (30.5%) and India (8.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.